| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 28 Jul 2025 | 22 Jul 2025 |
| Bharat Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/07/2025 inter alia to consider and approve Unaudited standalone and consolidated Financial Results for the quarter ended on June 30 2025. Appointment of Mr. Alkesh Shah as an Additional (Non-Executive Non-Independent) Director of the Company. Outcome of Board meeting held on July 28, 2025. (As Per BSE Announcement Dated on: 28.07.2025) | ||
| Board Meeting | 12 May 2025 | 5 May 2025 |
| Bharat Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2025 inter alia to consider and approve Board Meeting Intimation for the Quarter and Year ended on March 31 2025. Outcome of Board Meeting held on May 12, 2025. Appointment of Auditors. (As Per BSE Announcement Dated on: 12/05/2025) | ||
| Board Meeting | 15 Apr 2025 | 15 Apr 2025 |
| Intimation of Appointment of Company Secretary and compliance officer of the company. | ||
| Board Meeting | 3 Feb 2025 | 23 Jan 2025 |
| Bharat Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2025 inter alia to consider and approve unaudited standalone and consolidated financial results for the quarter ended on 31st December 2024 Unaudited standalone and consolidated Financial Results for the Quarter and nine months ended on 31st December,2024 (As Per BSE Announcement Dated on: 03/02/2025) | ||
| Board Meeting | 29 Oct 2024 | 19 Oct 2024 |
| Bharat Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2024 inter alia to consider and approve Intimation of Board meeting scheduled on 29th October 2024 to consider the unaudited Financial Result for quarter ended on 30th Sept. 2024 Financial Result for half year ended on 30th September, 2024 Intimation of Allotment of Equity shares 29th Oct, 24 and and re appointment of Mr. Bharat R. Desai, MD (As Per BSE Announcement dated on 29.10.2024) | ||
| Board Meeting | 31 Aug 2024 | 31 Aug 2024 |
| Intimation for appointment of Statutory Auditor | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.